Only 1 in 5 US nursing home residents given monoclonal antibodies, antivirals for COVID (By: Mary Van Beusekom, MS)
A new study published in JAMA finds that fewer than one in five US nursing home residents received evidenced-based treatment with monoclonal antibodies or oral antiviral drugs for COVID-19, despite being at high risk for poor outcomes. The rate…









